P - Contraindicated in pregnancy
L - Contraindicated in lactation
Silver sulfadiazine is a sulfa derivative topical antibacterial historically used as a topical burn cream on second- and third-degree burns. It prevents the growth of a wide array of bacteria, as well as yeast, on the damaged skin. Studies however have found that it increased healing times and is therefore no longer recommended.
Silver sulfadiazine is typically delivered in a 1% solution suspended in a water-soluble base. The chemical itself is poorly soluble, and has only very limited penetration through the skin. Only when applied to very large area burns is absorption into the body generally a problem.
Well-known proprietary brand names are Silvadene and Flamazine. The medication is also marketed under Kendall as Thermazene, with the aforementioned silvadene still functioning as a genericized trademark.
Silver sulfadiazine has broad antimicrobial activity; it is active against gram-positive and gram-negative bacteria as well as some yeasts and fungi. The silver salt acts mainly on the cell wall and membrane to disrupt its intergrity thus allowing it to impair the essential enzymes, bacterial DNA and RNA leading to cell death.
Absorption
Slowly releases sulfadiazine when it comes into contact with wound exudates. Up to 10% of sulfadiazine may be absorbed.
Information Not Available
Nausea, vomiting, diarrhoea; hypersensitivity, skin reactions; haematuria; crystalluria; thrombocytopenia, leucopenia, eosinophilia.
Potentially Fatal: Stevens-Johnson syndrome; agranulocytosis, jaundice, hepatitis.
Information Not Available
Impaired hepatic or renal function; G6PD deficiency; maintain adequate fluid intake. Monitor blood counts. Systemic absorption, resulting in argyria may occur if it is applied to large wound areas and over prolonged periods.
Potentiates antidiabetic effect of sulphonylureas. Not antagonised by PABA.
Information Not Available
Topical/Cutaneous
Treatment and prophylaxis of infection in severe burns
Adult: Apply a 1% cream onto affected area once or twice daily.
Information Not Available
Contraindicated in pregnancy
Contraindicated in lactation
Safety and efficacy not established
Information Not Available
Hypersensitivity to sulphonamides; porphyria; premature infants and infants <2 months; pregnancy and lactation.
Information Not Available
Information Not Available
You will hear from us only if the bid amount matches the minimum threshold and intended usage match our vision. You can resubmit another bid.